Emcure Pharmaceuticals Limited (NSE: EMCURE)
India flag India · Delayed Price · Currency is INR
1,420.70
+33.45 (2.41%)
Dec 24, 2024, 9:15 AM IST

Emcure Pharmaceuticals Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Revenue
72,56166,58359,85858,55450,33550,486
Upgrade
Revenue Growth (YoY)
13.13%11.23%2.23%16.33%-0.30%7.02%
Upgrade
Cost of Revenue
28,24825,35723,18522,86419,26920,748
Upgrade
Gross Profit
44,31341,22536,67335,69031,06529,737
Upgrade
Selling, General & Admin
16,62515,78013,06911,80510,27212,941
Upgrade
Other Operating Expenses
14,08012,76211,59710,5628,6069,621
Upgrade
Operating Expenses
34,74532,05227,45924,83521,40225,825
Upgrade
Operating Income
9,5689,1739,21410,8559,6633,912
Upgrade
Interest Expense
-1,888-1,949-1,629-1,325-1,140-2,046
Upgrade
Interest & Investment Income
207.59207.59118.34101.9769.8721.86
Upgrade
Currency Exchange Gain (Loss)
48.1248.12-29.88222.5430.33397.08
Upgrade
Other Non Operating Income (Expenses)
221.9-205.93-137.55-124.92-66.8-115.62
Upgrade
EBT Excluding Unusual Items
8,1587,2747,5369,7308,5572,170
Upgrade
Merger & Restructuring Charges
-99.31-99.31----
Upgrade
Impairment of Goodwill
------39.83
Upgrade
Gain (Loss) on Sale of Investments
25.3225.321.21---
Upgrade
Gain (Loss) on Sale of Assets
71.9271.92-3.33-4.084.29-41.57
Upgrade
Other Unusual Items
31.33--61.46--153.82-1,035
Upgrade
Pretax Income
8,1877,2727,4729,7258,4071,053
Upgrade
Income Tax Expense
2,2381,9971,8542,7002,33447.25
Upgrade
Earnings From Continuing Operations
5,9495,2765,6187,0266,0731,006
Upgrade
Earnings From Discontinued Operations
-----1,887-
Upgrade
Net Income to Company
5,9495,2765,6187,0264,1861,006
Upgrade
Minority Interest in Earnings
-276.39-293.92-298.26-403.56-264.47-170.03
Upgrade
Net Income
5,6734,9825,3206,6223,921836.07
Upgrade
Net Income to Common
5,6734,9825,3206,6223,921836.07
Upgrade
Net Income Growth
-5.51%-6.36%-19.66%68.87%369.04%-55.83%
Upgrade
Shares Outstanding (Basic)
183181181181181181
Upgrade
Shares Outstanding (Diluted)
183181181181181181
Upgrade
Shares Change (YoY)
1.11%0.01%----
Upgrade
EPS (Basic)
31.0227.5429.4236.6221.684.62
Upgrade
EPS (Diluted)
31.0227.5429.4236.6221.684.62
Upgrade
EPS Growth
-6.48%-6.38%-19.66%68.90%369.23%-55.86%
Upgrade
Free Cash Flow
6,5828,2153,5633,9005,7903,850
Upgrade
Free Cash Flow Per Share
36.0045.4219.7021.5632.0221.29
Upgrade
Dividend Per Share
--2.0003.0001.0002.500
Upgrade
Dividend Growth
---33.33%200.00%-60.00%-44.44%
Upgrade
Gross Margin
61.07%61.92%61.27%60.95%61.72%58.90%
Upgrade
Operating Margin
13.19%13.78%15.39%18.54%19.20%7.75%
Upgrade
Profit Margin
7.82%7.48%8.89%11.31%7.79%1.66%
Upgrade
Free Cash Flow Margin
9.07%12.34%5.95%6.66%11.50%7.63%
Upgrade
EBITDA
12,73011,80511,44612,91112,4196,657
Upgrade
EBITDA Margin
17.54%17.73%19.12%22.05%24.67%13.19%
Upgrade
D&A For EBITDA
3,1622,6322,2322,0572,7562,745
Upgrade
EBIT
9,5689,1739,21410,8559,6633,912
Upgrade
EBIT Margin
13.19%13.78%15.39%18.54%19.20%7.75%
Upgrade
Effective Tax Rate
27.33%27.45%24.81%27.76%27.77%4.49%
Upgrade
Revenue as Reported
73,55967,15260,31759,18950,67451,309
Upgrade
Advertising Expenses
-2,7881,8281,6331,2201,848
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.